Ewa Maj

1.3k total citations
43 papers, 999 citations indexed

About

Ewa Maj is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Ewa Maj has authored 43 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Organic Chemistry and 11 papers in Oncology. Recurrent topics in Ewa Maj's work include Synthesis and biological activity (16 papers), Synthesis and Biological Evaluation (13 papers) and Cancer therapeutics and mechanisms (11 papers). Ewa Maj is often cited by papers focused on Synthesis and biological activity (16 papers), Synthesis and Biological Evaluation (13 papers) and Cancer therapeutics and mechanisms (11 papers). Ewa Maj collaborates with scholars based in Poland, Canada and Italy. Ewa Maj's co-authors include Joanna Wietrzyk, Adam Huczyński, Michał Antoszczak, Jan Janczak, Bogumił Brzeziński, Diana Papiernik, Joanna Stefańska, Jack A. Tuszyński, Greta Klejborowska and Andrzej Kutner and has published in prestigious journals such as International Journal of Molecular Sciences, Developmental Biology and The Journal of Organic Chemistry.

In The Last Decade

Ewa Maj

40 papers receiving 992 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ewa Maj Poland 20 469 336 256 122 110 43 999
Michał Antoszczak Poland 22 583 1.2× 161 0.5× 363 1.4× 208 1.7× 242 2.2× 58 1.2k
Bożena Obmińska‐Mrukowicz Poland 16 431 0.9× 408 1.2× 101 0.4× 26 0.2× 18 0.2× 83 1.1k
Yongsheng Xie China 18 335 0.7× 322 1.0× 123 0.5× 14 0.1× 78 0.7× 84 1.0k
Suely Lins Galdino Brazil 22 513 1.1× 606 1.8× 90 0.4× 96 0.8× 7 0.1× 84 1.5k
Marko Anderluh Slovenia 26 1.2k 2.5× 774 2.3× 190 0.7× 96 0.8× 7 0.1× 105 2.1k
Jim Zhen Wu United States 31 780 1.7× 538 1.6× 200 0.8× 26 0.2× 47 0.4× 50 2.1k
Lisa Yan United States 18 787 1.7× 149 0.4× 132 0.5× 22 0.2× 27 0.2× 27 1.3k
Ching‐Ming Chien Taiwan 17 427 0.9× 120 0.4× 107 0.4× 31 0.3× 11 0.1× 41 746
Meng Zhou China 21 583 1.2× 497 1.5× 135 0.5× 42 0.3× 8 0.1× 75 1.2k
Anuraag Shrivastav Canada 17 569 1.2× 300 0.9× 246 1.0× 25 0.2× 13 0.1× 48 1.1k

Countries citing papers authored by Ewa Maj

Since Specialization
Citations

This map shows the geographic impact of Ewa Maj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Maj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Maj more than expected).

Fields of papers citing papers by Ewa Maj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewa Maj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Maj. The network helps show where Ewa Maj may publish in the future.

Co-authorship network of co-authors of Ewa Maj

This figure shows the co-authorship network connecting the top 25 collaborators of Ewa Maj. A scholar is included among the top collaborators of Ewa Maj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewa Maj. Ewa Maj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Antoszczak, Michał, Greta Klejborowska, Szymon Sobczak, et al.. (2025). Effect of stereochemistry at position C20 on the antiproliferative activity and selectivity of N-acylated derivatives of salinomycin. European Journal of Medicinal Chemistry. 291. 117598–117598.
3.
Aminpour, Maral, Jan Janczak, Ewa Maj, et al.. (2021). An insight into the anticancer potential of carbamates and thiocarbamates of 10-demethoxy-10-methylaminocolchicine. European Journal of Medicinal Chemistry. 215. 113282–113282. 19 indexed citations
4.
Maj, Ewa, et al.. (2021). Differential Response of Lung Cancer Cells, with Various Driver Mutations, to Plant Polyphenol Resveratrol and Vitamin D Active Metabolite PRI-2191. International Journal of Molecular Sciences. 22(5). 2354–2354. 17 indexed citations
5.
Sobczak, Szymon, et al.. (2020). Synthesis and Antiproliferative Screening Of Novel Analogs of Regioselectively Demethylated Colchicine and Thiocolchicine. Molecules. 25(5). 1180–1180. 13 indexed citations
6.
Aminpour, Maral, Jan Janczak, Ewa Maj, et al.. (2020). Synthesis, Antiproliferative Activity and Molecular Docking Studies of Novel Doubly Modified Colchicine Amides and Sulfonamides as Anticancer Agents. Molecules. 25(8). 1789–1789. 56 indexed citations
7.
Aminpour, Maral, et al.. (2020). New Series of Double-Modified Colchicine Derivatives: Synthesis, Cytotoxic Effect and Molecular Docking. Molecules. 25(15). 3540–3540. 14 indexed citations
8.
Sobczak, Szymon, Tomasz Pędziński, Ewa Maj, et al.. (2020). Photoinduced Skeletal Rearrangement of N-Substituted Colchicine Derivatives. The Journal of Organic Chemistry. 86(16). 11029–11039. 3 indexed citations
9.
Maj, Ewa, et al.. (2020). Synthesis and Anticancer Activity of Dimeric Polyether Ionophores. Biomolecules. 10(7). 1039–1039. 11 indexed citations
10.
Klejborowska, Greta, Ewa Maj, Jordane Preto, et al.. (2019). Synthesis, antiproliferative activity, and molecular docking studies of 4‐chlorothiocolchicine analogues. Chemical Biology & Drug Design. 95(1). 182–191. 4 indexed citations
11.
Klejborowska, Greta, Alicja Urbaniak, Jordane Preto, et al.. (2019). Synthesis, biological evaluation and molecular docking studies of new amides of 4-bromothiocolchicine as anticancer agents. Bioorganic & Medicinal Chemistry. 27(23). 115144–115144. 11 indexed citations
12.
Klejborowska, Greta, Ewa Maj, Joanna Wietrzyk, Joanna Stefańska, & Adam Huczyński. (2018). One‐pot synthesis and antiproliferative activity of novel double‐modified derivatives of the polyether ionophore monensin A. Chemical Biology & Drug Design. 92(2). 1537–1546. 3 indexed citations
13.
Klejborowska, Greta, Ewa Maj, Joanna Wietrzyk, et al.. (2018). Antiproliferative Activity and Molecular Docking of Novel Double-Modified Colchicine Derivatives. Cells. 7(11). 192–192. 30 indexed citations
14.
Klejborowska, Greta, Ewa Maj, Joanna Wietrzyk, et al.. (2018). Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer Agents. Cells. 7(11). 216–216. 27 indexed citations
15.
Antoszczak, Michał, Alicja Urbaniak, Ewa Maj, et al.. (2018). Biological activity of doubly modified salinomycin analogs – Evaluation in vitro and ex vivo. European Journal of Medicinal Chemistry. 156. 510–523. 31 indexed citations
16.
Maj, Ewa, et al.. (2016). Controlled levels of canonical Wnt signaling are required for neural crest migration. Developmental Biology. 417(1). 77–90. 36 indexed citations
17.
Maj, Ewa, Diana Papiernik, & Joanna Wietrzyk. (2016). Antiangiogenic cancer treatment: The great discovery and greater complexity (Review). International Journal of Oncology. 49(5). 1773–1784. 105 indexed citations
18.
Huczyński, Adam, Greta Klejborowska, Michał Antoszczak, Ewa Maj, & Joanna Wietrzyk. (2015). Anti-proliferative activity of Monensin and its tertiary amide derivatives. Bioorganic & Medicinal Chemistry Letters. 25(20). 4539–4543. 19 indexed citations
19.
Antoszczak, Michał, et al.. (2015). Synthesis and antiproliferative activity of new bioconjugates of Salinomycin with amino acid esters. Bioorganic & Medicinal Chemistry Letters. 25(17). 3511–3514. 21 indexed citations
20.
Antoszczak, Michał, Ewa Maj, Agnieszka Napiórkowska, et al.. (2014). Synthesis, Anticancer and Antibacterial Activity of Salinomycin N-Benzyl Amides. Molecules. 19(12). 19435–19459. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026